Mark Lawrence Johnson, PhD, MBA is a global health security economist and industry expert passionately dedicated to challenging the status quo concerning international availability and sustainability for countermeasures against chemical, biological, radiological, and nuclear (CBRN) agents and rare diseases. He would like to contribute to consortium projects by determining ways to strengthen the sustainability of relevant R&D public funding and defining/implementing the process to commercialize new products.

 Développement durable

 Médicaments

 Équipement médical

 Coopération internationale

 Biotechnologie médicale

 Design industriel

 Gestion de projets internationaux

 Développement des affaires

 Sociologie et recherche économique

 Évaluation des politiques et gouvernance